Transaction DateRecipientSharesTypePriceValue
16th October 2020Brendan Kennedy400,000Open or private sale$5.60$2,238,560.00
15th October 2020Brendan Kennedy400,000Open or private sale$5.61$2,243,160.00
14th October 2020Brendan Kennedy400,000Open or private sale$5.83$2,331,320.00
1st October 2020Edward Wood Jr Pastorius1,812Payment by withholding$0.00
1st October 2020Michael Auerbach2,188Exercise of derivative$0.00
1st October 2020Brendan Kennedy46,875Exercise of derivative$0.00
1st October 2020Edward Wood Jr Pastorius6,250Exercise of derivative$0.00
1st October 2020Brendan Kennedy11,415Payment by withholding$0.00
30th September 2020Brendan Kennedy8,252,161Conversion of derivative$0.00
30th September 2020Brendan Kennedy158,746Conversion of derivative$0.00
Tilray
Tilray logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.


Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. Its products include dried cannabis and cannabis extracts. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.


Ticker: TLRY
Sector: Process Industries
Industry: Agricultural Commodities/Milling
SEC Central Index Key (CIK): 1731348
Employees: 1646
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $137 M (0%)
Inventory, Net: $93 M (0%)
Assets, Current: $290 M (11%)
Property, Plant and Equipment, Net: $176 M (0%)
Other Assets, Noncurrent: $4 M (-42%)
Assets: $856 M (-4%)
Accounts Payable, Current: $22 M (-43%)
Liabilities, Current: $164 M (77%)
Other Liabilities, Noncurrent: $5 M (-9%)
Liabilities: $724 M (18%)
Retained Earnings (Accumulated Deficit): $725 M (68%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $231 Th (0%)
Stockholders' Equity (Parent): $131 M (0%)
Liabilities and Equity: $856 M (-4%)
Gross Margin: $5 M (0%)
Research and Development: $652 Th (0%)
Sales and Marketing: $13 M (0%)
General and Administrative Expenses: $14 M (0%)
Operating Income/Loss: $76 M (-48%)